Avalon GloboCare back in full Nasdaq compliance

Avalon GloboCare Corp. announced that Nasdaq has notified the company it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Listing Rule 5550(b).

Rhea-AI Filing Summary

Avalon GloboCare Corp. announced that Nasdaq has notified the company it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Listing Rule 5550(b). Nasdaq also confirmed that the company is now in compliance with all applicable continued listing standards, meaning its common stock will continue to trade on the Nasdaq Capital Market. A previously scheduled hearing before the Nasdaq Hearings Panel has been cancelled, and the company issued a press release describing these developments.

Positive

• Nasdaq compliance restored: The company has regained compliance with Nasdaq Capital Market’s minimum stockholders’ equity requirement and all continued listing standards, avoiding a potential delisting hearing.

Negative

• None.

Insights

Equity markets analyst

Nasdaq confirms Avalon GloboCare is back in full listing compliance.

Avalon GloboCare has received notice from Nasdaq that it once again meets the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Listing Rule 5550(b). Nasdaq further confirmed that the company now satisfies all applicable continued listing standards, removing a key overhang related to potential delisting.

This development cancels the previously scheduled hearing before the Nasdaq Hearings Panel and ensures the company’s common stock will continue to be listed and traded on the Nasdaq Capital Market. Avoiding a delisting scenario helps preserve access to a major exchange, which is often important for liquidity and institutional participation, based solely on the information disclosed.

8-K Event Classification

3 items: 7.01, 8.01, 9.01

3 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Avalon GloboCare Corp. (ALBT) announce regarding its Nasdaq listing?

Avalon GloboCare Corp. announced that Nasdaq has notified the company it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Listing Rule 5550(b) and is now in compliance with all applicable continued listing standards.

Is Avalon GloboCare Corp. (ALBT) still listed on the Nasdaq Capital Market?

Yes. Nasdaq confirmed that Avalon GloboCare Corp.’s common stock will continue to be listed and traded on the Nasdaq Capital Market after the company regained full compliance with listing requirements.

What happened to Avalon GloboCare Corp.’s scheduled Nasdaq Hearings Panel meeting?

As a result of regaining compliance with Nasdaq’s minimum stockholders’ equity requirement and other continued listing standards, the previously scheduled hearing before the Nasdaq Hearings Panel has been cancelled.

Which specific Nasdaq rule did Avalon GloboCare Corp. (ALBT) regain compliance with?

Avalon GloboCare Corp. regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b).

Did Avalon GloboCare Corp. issue a press release about regaining Nasdaq compliance?

Yes. The company issued a press release dated January 12, 2026, which is attached as Exhibit 99.1 and describes the notice from Nasdaq and the company’s renewed compliance status.

Does the Nasdaq compliance information affect Avalon GloboCare’s other SEC filings?

The company stated that the information under this disclosure, including the press release, is not deemed filed for purposes of Section 18 of the Exchange Act and is not automatically incorporated by reference into other Securities Act or Exchange Act filings unless specifically referenced.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/12/2026 - 09:03 AM Learn about SEC filing dates

false 0001630212 0001630212 2026-01-12 2026-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 12, 2026

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware		001-38728		47-1685128
(State or other jurisdiction		(Commission File Number)		(I.R.S. Employer
of incorporation)				Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On January 12, 2026, Avalon GloboCare Corp. (the “Company”) issued a press release announcing that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b), and that it is now in compliance with all applicable continued listing standards.

The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information included in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information contained herein that is required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 8.01. Other Events.

As disclosed in Item 7.01 above, Nasdaq has confirmed that the Company has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b), and that it is now in compliance with all applicable continued listing standards. As a result, the previously scheduled hearing before the Nasdaq Hearings Panel has been cancelled, and the Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market.

Item 9.01. Financial Statement and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press release of the Company dated January 12, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.
Dated: January 12, 2026	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

2